NATCO Pharma Limited 2024-04-17 Health serious FDA
Health · FDA · Recall #FDA-D-0438-2024
Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent… Recall
Issued April 17, 2024 · NATCO Pharma Limited
In April 2024, NATCO Pharma Limited recalled the Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations
What you should do
- 1 Stop using Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact NATCO Pharma Limited to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- NATCO Pharma Limited
- Category
- Health
- Recall date
- April 17, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the US
- Recall number
- FDA-D-0438-2024
- Made in
- India
- Issuing agency
- FDA
In context
- NATCO Pharma Limited has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.